The human life is simple as well as quite intrigued and it always tries to find solutions to unending problems and challenges. We know that the need is the mother of invention and the scientists in the world are saints of modern age, as based on their tireless efforts the humans have made a significant progress in various fields as telecommunications, information technology, space technology, infrastructures, food technology through green revolution, life-saving drugs, etc. All these fields need chemicals, which must be manufactured at commercial scales. However, the old technologies are handicapped with unlimited limitations for commercial production of these much needed chemicals. As an old man needs help to cross the road, such limitations in the commercial productions of these chemicals are overcome with co-operative effects of other additives as promoters of reaction rates, which in turn help produce the desired products in quantitative yields. Isn't it interesting to find out what kind of these

promoters are, as they have been identified and successfully used through a long journey of innovative, cost-effective process developments with excellent yields and purities of the targeted molecules, which find number of applications in human life. New technologies with above attributes are the essence of this book entitled as "Aniline and its Analogs," which covers the old and new methods and technologies of their preparations and manufacturing till date, which is compiled by a versatile and an accomplished scientist.
About the Author: The author is a Ph.D. holder from National Chemical Laboratory (NCL), Pune, India, which is one of the most prestigious institutes in the world. He has about 35 years of experience in Synthetic Organic Chemistry, Medicinal Chemistry, Biochemistry, Molecular Biology, Biotechnology, especially five years on Human Genome Project at Baylor College of Medicine, Houston, Texas. He has worked in small, medium and multinational companies in India and USA in senior positions as Associate Director, General Manager, Vice President, President and CEO and also as an Entrepreneur. He was responsible for leading large groups (up to 70-80 people) and developing drug molecules both as New Chemical Entities (NCEs) and cost-effective process development of commercially required drugs as antihistamines, anticancer, anti-diabetes, drugs for heart diseases, obesity, and also specialty chemicals. The processes involved multi-step synthesis of the drugs under these headings and also intermediates for drug molecules. He has

published about 18 publications in international journals and has 13 patents to his credit. He is an invited speaker at conferences, colleges, institutes and industries and a Chief Guest and a Key-Note Speaker at a UGC Conference. He has published a book on Cancer, "Understanding Cancer at the Subcellular Level," published by Nova Publishers, New York, USA.